Metabolic Engineering Strategy for Producing High-Value Products in Microalgae
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 31 January 2025 | Viewed by 26
Special Issue Editors
Interests: high-density cultivation of microalgae; metabolic engineering of microalgae; microalgal biorefining
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
High-value products derived from microalgae have garnered considerable attention as valuable resources for drugs, functional foods, and cosmetics. Several microalgae species have been identified as rich sources of bioactive compounds, including the Chlorophyceae Dunaliella, the dinoflagellate Crypthecodinium cohnii, and the Bacillariophyta Phaeodactylum and Nitzschia.
Metabolic engineering strategies are efficient in optimizing biochemical pathways for the enhanced production of high-value compounds in microalgae cultivation. These approaches leverage genetic and biochemical tools to manipulate metabolic fluxes and improve the yields of target products, such as omega-3 fatty acids and pigments, thereby advancing their biotechnological potential for sustainable productions.
For this Special Issue, we invite academic and industry scientists to submit reviews and original and conceptual research articles focusing on the application of diverse metabolic engineering strategies for producing high-value products from microalgae, alongside the analysis and clarification of their biosynthetic pathways.
Dr. Han Sun
Dr. Shufang Yang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic engineering
- high-value product
- cell factory
- synthetic biology
- omics analysis
- microalgae
